Al Hammadi Holding’s unit to provide NUPCO with vaccines

Getty Images

At a total value of $10.13mln, Al Hammadi Holding’s unit will provide NUPCO with the vaccines in the fourth quarter (Q4) of 2022

Staff Writer, Mubasher

September 5, 2022

PHOTO

Riyadh – A fully-owned subsidiary of Al Hammadi Holding, formerly known as Al Hammadi Company for Development and Investment, has been awarded a contract to supply vaccines to the National Unified Procurement Company (NUPCO).

At a total value of SAR 38 million, Al Hammadi Holding’s unit will provide NUPCO with the vaccines in the fourth quarter (Q4) of 2022, according to a bourse filing on Sunday.

The Saudi-listed firm noted that the award and sign dates of the contract are 4 September 2022.

It is worth mentioning that during the first half (H1) of 2022, Al Hammadi Holding achieved net profits worth SAR 127.06 million, higher by 67.54% than SAR 75.84 million.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.